Abundance Wealth Counselors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $285K | Sell |
4,131
-212
| -5% | -$14.6K | 0.05% | 140 |
|
|
2025
Q1 | $302K | Buy |
4,343
+55
| +1% | +$3.83K | 0.06% | 131 |
|
|
2024
Q4 | $369K | Buy |
4,288
+541
| +14% | +$46.6K | 0.08% | 120 |
|
|
2024
Q3 | $446K | Buy |
+3,747
| New | +$446K | 0.09% | 118 |
|
|
2024
Q2 | – | Sell |
-3,813
| Closed | -$490K | – | 124 |
|
|
2024
Q1 | $490K | Buy |
3,813
+451
| +13% | +$58K | 0.11% | 106 |
|
|
2023
Q4 | $348K | Sell |
3,362
-114
| -3% | -$11.8K | 0.09% | 113 |
|
|
2023
Q3 | $316K | Buy |
+3,476
| New | +$316K | 0.09% | 108 |
|
|
2023
Q2 | – | Sell |
-4,540
| Closed | -$361K | – | 120 |
|
|
2023
Q1 | $361K | Sell |
4,540
-98
| -2% | -$7.79K | 0.09% | 112 |
|
|
2022
Q4 | $314K | Sell |
4,638
-278
| -6% | -$18.8K | 0.09% | 114 |
|
|
2022
Q3 | $245K | Buy |
4,916
+10
| +0.2% | +$498 | 0.07% | 121 |
|
|
2022
Q2 | $273K | Buy |
4,906
+294
| +6% | +$16.4K | 0.07% | 119 |
|
|
2022
Q1 | $256K | Buy |
+4,612
| New | +$256K | 0.07% | 127 |
|
|
2021
Q2 | – | Sell |
-1,758
| Closed | -$59K | – | 255 |
|
|
2021
Q1 | $59K | Buy |
+1,758
| New | +$59K | 0.01% | 159 |
|